Article
Medulloblastoma and other neoplasms in patients with heterozygous germline SUFU variants: A scoping review.
American journal of medical genetics. Part A - 1 Jun 2024
Lee Stephanie G, Evans Gareth, Stephen Maddie, Goren Rachel, Bondy Melissa, Goodman Steven
Abstract excerpt
In 2002, heterozygous suppressor of fused variants (SUFU+/-) in the germline were described to have a tumor suppressor role in the development of pediatric medulloblastoma (MB). Other neoplasms associated with pathologic germline SUFU+/- variants have also been described among patients with basal cell nevus syndrome (BCNS; BCNS is also known as Gorlin syndrome, nevoid basal cell carcinoma [BCC] syndrome or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
